Valuation: Gencurix Inc.

Market Cap 30.03B 20.64M 18.11M 16.87M 15.51M 29.08M 1.97B 29.58M 200M 78.33M 978M 77.49M 75.81M 3.38B P/E 2022
-1.86x
P/E 2023 -3.82x
Enterprise Value 35.66B 24.51M 21.51M 20.03M 18.42M 34.54M 2.34B 35.13M 238M 93.02M 1.16B 92.02M 90.03M 4.01B EV / Sales 2022
26.8x
EV / Sales 2023 34.6x
Free-Float
55.38%
Yield 2022 *
-
Yield 2023 -
1 day-5.92%
1 week-2.44%
Current month-32.93%
1 month-28.38%
3 months-37.06%
6 months-18.60%
Current year-4.64%
1 week 1,454
Extreme 1454
1,680
1 month 1,450
Extreme 1450
2,300
Current year 1,450
Extreme 1450
7,320
1 year 1,385
Extreme 1385
7,320
3 years 1,131
Extreme 1131
8,910
5 years 1,131
Extreme 1131
23,500
10 years 1,131
Extreme 1131
32,300
Manager TitleAgeSince
Chief Executive Officer 53 -
Chief Tech/Sci/R&D Officer 64 2014-12-31
Corporate Officer/Principal 61 2023-03-30
Director TitleAgeSince
Director/Board Member 53 -
Director/Board Member 61 2023-03-30
Director/Board Member 43 2023-09-12
Change 5-day change 1-year change 3-year change Capi.($)
-5.92%-2.44%-8.87%-51.35% 23.81M
-1.27%-5.69%+224.42%+269.96% 19.04B
-1.73%+4.87%-41.87%-24.92% 10.07B
-4.99%-4.92%+41.75%+16.70% 6.68B
+2.46%-0.32%+221.38%-25.21% 5.97B
+1.43%+3.81%-15.83%-20.90% 5.53B
-0.26%-0.89%-42.39% - 4.41B
-0.20%+5.31%-21.48%-30.86% 4.26B
-7.42%-15.95%+71.13%+88.98% 4.15B
+0.03%-2.33%-20.60%-44.59% 2.69B
Average -1.83%-3.01%+40.76%+19.76% 6.28B
Weighted average by Cap. -1.43%-2.42%+84.76%+83.03%

Financials

2022 2023
Net sales 2.56B 1.76M 1.54M 1.44M 1.32M 2.48M 168M 2.52M 17.06M 6.68M 83.35M 6.6M 6.46M 288M 2.6B 1.79M 1.57M 1.46M 1.34M 2.52M 171M 2.56M 17.33M 6.78M 84.68M 6.71M 6.56M 293M
Net income -24.6B -16.91M -14.84M -13.82M -12.71M -23.82M -1.62B -24.23M -164M -64.15M -801M -63.47M -62.09M -2.77B -19.26B -13.24M -11.62M -10.82M -9.95M -18.65M -1.26B -18.97M -128M -50.23M -627M -49.7M -48.62M -2.17B
Net Debt 22.55B 15.5M 13.6M 12.67M 11.65M 21.84M 1.48B 22.21M 150M 58.81M 734M 58.18M 56.93M 2.54B 5.63B 3.87M 3.4M 3.16M 2.91M 5.46M 370M 5.55M 37.54M 14.69M 183M 14.53M 14.22M 634M
Logo Gencurix Inc.
Gencurix Inc. is a Korea-based company mainly engaged in the sale of medical equipments. In addition, the Company is involved in the manufacturing and sale of breast cancer test (BCT) kits, Korean genetic polymorphism diagnostic kits, lung cancer and colorectal cancer diagnostic kits. The BCT kits are used for analyzing the expression level of the cancer-related gene. The products are sold under the name of GenesWell.
Employees
-
Date Price Change Volume
26-07-28 ₩1,479.00 -5.92% 89,401
26-07-27 ₩1,572.00 -2.90% 61,841
26-07-24 ₩1,619.00 -3.00% 62,499
26-07-23 ₩1,669.00 +4.44% 90,565
26-07-22 ₩1,598.00 +5.41% 138,250
  1. Stock Market
  2. Stocks
  3. A229000 Stock